MGRX · Mangoceuticals, Inc. · Proposed Sales
$0.30
+0.02 (+7.10%)
At close · Oct 20
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These factors raise substantial doubt about the ability of the Company to continue as a going concern. Unless management is able to obtain additional financing, it is unlikely that the Company will be able to meet its funding requirements during the 12 months from the date of issuance of this filing.”View the 10-Q filed Aug 13, 2026
Market Cap
$6.04M
Shares
21.57M
Volume · Oct 20
178.27K
Avg daily vol (3M)
12.64M
Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.
| Filed | Seller | Relationship | Shares | Approx. Sale | Broker |
|---|---|---|---|---|---|
| 2025-12-03 | JOHNSTON EUGENE M | Officer | 128,333 | 2025-12-03 | Charles Schwab & Co |
| 2025-11-19 | Hamilton Alex P. | Director | 125,000 | 2025-11-19 | The Charles Schwab Corporation |
| 2024-06-18 | Alex P. Hamilton | Board of Directors | 50,000 | 2024-06-21 | Charles Schwab |
| 2024-06-10 | Alex P. Hamilton | Self | 50,000 | 2024-06-10 | Fidelity |
Showing 1–4 of 4 filings